Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 884Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Deva Holding AS

02 5Devatis AG

03 4ROCHE SpA

04 11Roche Pharma (Schweiz) AG

05 1TEVA ITALIA Srl

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG; 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name :

Dosage Form : Prolonged Release Hard Capsule

Dosage Strength : 100MG; 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Levodopa/Benserazid Devatis

Dosage Form : Tabl

Dosage Strength : 125mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopum; Benserazidum

Brand Name : Levodopa/Benserazid Devatis

Dosage Form : Tabl

Dosage Strength : 125mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 200+50Mg 50 Combined Oral Use

Dosage Strength : 50 CPR 200 mg + 50 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 100+25Mg 30 Joined' Oral Use

Dosage Strength : 30 cps 100 mg + 25 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 100+25Mg 30 Joined' Oral Use

Dosage Strength : 30 cpr dispers 100 mg + 25 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Madopar

Dosage Form : Levodopa+Benserazide 100+25Mg 30 Joined' Oral Use Rp

Dosage Strength : 30 cps 100 mg + 25 mg prolonged release

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Levodopa; Benzerazide hydrochloride

Brand Name : Lodopa Benserazide

Dosage Form : Levodopa+Benserazide 200+50Mg 50 Combined Oral Use

Dosage Strength : 50 CPR 200 mg + 50 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank